Clinical Trial Update: A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or Monofer [Phase 4]

View source ↗

Summary

Phase 4 trial comparing iron substitution with Ferinject or Monofer in patients with iron-deficiency anemia; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• Ferinject (ferric carboxymaltose)
• Monofer (Ferric derisomaltose)

Snippet

Sponsor: Universität des Saarlandes | Conditions: Anemia, Iron-Deficiency | Phase 4 | Status: COMPLETED